Sign In
Buy ZYXI
$0.125
+0 (+0%)
At Close: Mar 20, 2026
Zynex: Order Growth, Already At +140%, Is Set To Accelerate
08:53am, Wednesday, 05'th May 2021
Order growth, and with it revenue growth, will accelerate again after already raking up a 140% growth in Q1.
Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q1 2021 Results - Earnings Call Transcript
11:34pm, Thursday, 29'th Apr 2021
Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q1 2021 Results - Earnings Call Transcript
Zynex Announces 2021 First Quarter Earnings
04:01pm, Thursday, 29'th Apr 2021
ENGLEWOOD, Colo., April 29, 2021 /PRNewswire/ -- 2021 First Quarter Revenue increased 58% year over year to $24.1 million Orders increased 140% Net loss of $0.7 million; GAAP loss per share $0.02 Adju
Zynex Appoints Donald Gregg as Vice President of Sales and Operations of Monitoring Solutions Division
09:15am, Tuesday, 20'th Apr 2021
ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa
Zynex Schedules 2021 First Quarter Earnings Call
09:15am, Monday, 19'th Apr 2021
ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa
Zynex Announces 140% Year over Year Order Growth in Q1-2021
09:15am, Monday, 12'th Apr 2021
ENGLEWOOD, Colo., April 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain m
Zynex Growth Leads to New Corporate Headquarters
09:15am, Friday, 09'th Apr 2021
ENGLEWOOD, Colo., April 9, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Recognized as the Sixth Largest Biotechnology/Bioscience Company in Colorado
09:15am, Tuesday, 30'th Mar 2021
ENGLEWOOD, Colo., March 30, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa
Why Zynex Stock Is Crashing Today
12:12pm, Friday, 26'th Feb 2021
Investors are reacting negatively to the company's Q4 results and Q1 outlook.
Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q4 2020 Results - Earnings Call Transcript
10:44pm, Thursday, 25'th Feb 2021
Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q4 2020 Results - Earnings Call Transcript
Recap: Zynex Q4 Earnings
05:35pm, Thursday, 25'th Feb 2021
Shares of Zynex (NASDAQ:ZYXI) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 44.44% over the past year to $0.05, which missed the es
Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call
09:15am, Thursday, 18'th Feb 2021
ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m
Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical
04:30pm, Thursday, 28'th Jan 2021
ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m
Zynex Announces Filing of Patent for Sepsis Monitor
09:15am, Thursday, 14'th Jan 2021
ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m
Zynex Ranked 13th in Revenue Growth Among Medical Device Companies
09:15am, Thursday, 19'th Nov 2020
ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m
